Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

Survey: Pharma bullish on digital innovation, but failing on execution

GSK, iTeos take stock after Roche’s TIGIT setback

FDA rejects UCB’s psoriasis therapy bimekizumab

Pfizer: Pharma needs a business strategy for a digital world

Gedeon Richter gets NICE nod for uterine fibroids drug Ryeqo

Affimed

Cancer attacked by T cells 600

News/ News/ Oncology

AACR: Affimed builds case for natural killer cell therapy

Phil Taylor Affimed, bispecific antibody, classical Hodgkin lymphoma, immuno-oncology, natural killer cell, non-Hodgkin lymphoma, Oncology 0 Comment

Affimed says new data from a phase 1/2 trial of its natural killer (NK) cell engager therapy AFM13

X

AACR: Affimed builds case for natural killer cell therapy

https://pharmaphorum.com/news/aacr-affimed-builds-case-for-natural-killer-cell-therapy/

Affimed and Roche ink $5bn plus cancer immunotherapy deal

News/ News/ Oncology/ Top stories

Affimed and Roche ink $5bn plus cancer immunotherapy deal

Richard Staines Affimed, cancer immunotherapy, Genentech, Roche 0 Comment

Deal is based on natural killer cell therapeutics

X

Affimed and Roche ink $5bn plus cancer immunotherapy deal

https://pharmaphorum.com/news/affimed-and-roche-ink-5bn-plus-cancer-immunotherapy-deal/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

FDA rejects UCB's psoriasis therapy bimekizumab
GSK, iTeos take stock after Roche's TIGIT setback
Gedeon Richter gets NICE nod for uterine fibroids drug Ryeqo
Insulin producers face fresh lawsuit in US over pricing
BMS doubles down on BridgeBio alliance on SHP2 drugs

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com